GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Feb 23, 2024 · 10-K · 54 days after period end · 0001818331-24-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 | Q4 2020 |
|---|---|---|---|---|
| Revenue | $57.42M | $61.35M | $57.80M | $63.96M |
| Net Income | -$25.77M | -$308.76M | -$40.19M | -$125.68M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 23, 2024 · 54 d after period end
